Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Neurostimulation for chronic upper limb pain after brachial plexus injury

Official title: High Frequency Spinal Cord Stimulation for Neuropathic Pain Following Brachial Plexus Avulsion Injury: a Prospective Observational Cohort Study

Run by Mayo Clinic · NCT04733599 · Data updated 2026-11-12

This study is testing if spinal cord stimulation can help adults with chronic pain from a brachial plexus injury feel less pain over time.

More Brachial Plexus Birth Palsy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorMayo Clinic
Academic / other
Locations2 sites (Jacksonville, Florida and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2021
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMarch 2, 2026
Trial IDNCT04733599 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with neuropathic pain in the upper limb lasting at least three months following a brachial plexus avulsion injury.

Probably not a fit

Patients with non-neuropathic pain, active substance use disorders, or those who have not undergone conservative medical management may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to evaluate the impact of high frequency spinal cord stimulation therapy on pain intensity in adults suffering from chronic neuropathic pain due to brachial plexus avulsion injury. Participants will be adults over 18 years old who are candidates for spinal cord stimulation. The study will observe these patients after the implantation of the stimulation device to assess changes in pain levels over time.

Why it matters

Potential benefit: If successful, this approach could significantly reduce chronic pain and improve the quality of life for patients with brachial plexus injuries.

How similar studies have gone: Other studies have shown promising results with spinal cord stimulation for neuropathic pain, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years old
* Neuropathic pain of the upper limb ≥ 3 months following brachial plexus avulsion injury.
* Patients must be planned to undergo implantation of high-frequency spinal cord stimulation for the treatment of chronic neuropathic pain due to brachial plexus avulsion injury.

Exclusion Criteria:

* Pain that is non-neuropathic as defined by DN4 score \<4.
* Pregnant at the time of consideration for implant or planning to become pregnant during the study duration.
* Active substance use disorder of any kind.
* Active tobacco use.
* Use of moderate or high dose opioid medication (oral morphine equivalents \>100 mg daily).
* Active, untreated major psychiatric disorder that might interfere with subject's ability to participate.
* Involvement in active litigation related to injury.
* Patient has not undergone conservative medical management for at least 3 months (including physical and/or occupational therapy and at least one trial of neuropathic pain medication).

Where it's running

  • Mayo Clinic
    Jacksonville, Florida, United States
    Recruiting
  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Christy Hunt, DO — Mayo Clinic

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.